ClinicalTrials.Veeva

Menu

Novel Dementia Biomarkers

G

German Center for Neurodegenerative Diseases (DZNE)

Status

Unknown

Conditions

Alzheimer Disease, Early Onset

Treatments

Other: No Intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study will investigate structural and functional characteristics of the brain of dementia patients compared to healthy controls in order to get a better insight into importance of early biomarkers for the diagnosis of Alzheimer's dementia. The methods for obtaining biomarkers incude magnetic resonance imaging (MRI), near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), electrocardiography (ECG) and neurophyshological assessments. Special parameters are being studied that have already been shown to detect changes in the early stages of Alzheimer's dementia.

Enrollment

100 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinically diagnosed MCI patients and matched healthy controls

Exclusion criteria

  • Metal in body and tatoos;
  • Other chronic systemic neurological, cardiologic, metabolic or musculo-skeletal diseases which have been proven to influence the outcome variables
  • Alcohol abuse
  • Colour blindness
  • Pregnancy
  • Surgery in the last 6 months
  • Uncorrected vision

Trial design

100 participants in 2 patient groups

Patients
Description:
Mild Cognitive Impairment (clinical determination)
Treatment:
Other: No Intervention
Control
Description:
Healthy Elderly
Treatment:
Other: No Intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems